Answers are grounded in this paper and cite their sources.
Bloodstream infections (BSIs) caused by Candida species are a major cause of morbidity and mortality in critically ill patients. While early antifungal therapy is crucial, inappropriate use drives resistance and escalates costs, necessitating structured Antifungal Stewardship (AFS) programs. To evaluate the impact of implementing an AFS program on the incidence of fungal infections, the quality of antifungal prescribing, antifungal consumption and costs, and clinical outcomes in a surgical Intensive Care Unit (ICU). A prospective, quasi-experimental study was conducted over 18 months in a 25-bed surgical ICU at Zagazig University Hospitals. The study comprised three 6-month phases: baseline (observational), implementation (interventional education and policy), and programme continuation (prospective audit and feedback). A total of 270 patients with risk factors for fungal infection were enrolled (135 per phase). The primary outcome was the change in Candida infection incidence. Secondary outcomes included prescription quality scores, antifungal consumption in Defined Daily Doses (DDD), costs, and clinical outcomes. Physician knowledge was assessed via pre- and post-intervention questionnaires. The incidence of Candida infection showed a non-significant numerical reduction from 22.2% to 20.0% ( p = 0.997). However, the AFS program significantly improved the global quality of antifungal prescribing, with the total prescription adequacy score increasing from 6.1 ± 1.5 to 7.8 ± 1.5 ( p = 0.007). Physician knowledge and attitude scores improved markedly from 12.7 ± 3.9 to 21.0 ± 2.8 ( p < 0.001). Favorable but non-significant trends were observed in antifungal costs, ICU length of stay (LOS), and mechanical ventilation duration. In-hospital mortality remained stable (55.6% vs. 54.8%; p = 1.000), confirming the intervention’s safety. Implementation of a multifaceted AFS program in a resource-limited surgical ICU significantly enhanced the quality of antifungal prescribing and physician knowledge without compromising patient safety. While immediate reductions in infection incidence were not statistically significant, the improvements in key process measures are essential prerequisites for long-term clinical and economic benefits. The findings strongly support the integration of routine AFS into critical care practice.
No takes yet. Share an insight, caveat, or question.
Negm et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: